BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Improving base editing with recombinant editor proteins

By Claire Quang, Staff Writer
October 1, 2021 5:02 AM UTC

DISEASE CATEGORY: Ophthalmic

INDICATION: Ophthalmic...

BCIQ Company Profiles

Hanyang University

Korea University

Seoul National University Hospital

BCIQ Target Profiles

Retinal pigment epithelium-specific protein 65kDa (RPE65)

BCIQ Company Profiles

Hanyang University

Korea University

Seoul National University Hospital

BCIQ Target Profiles

Retinal pigment epithelium-specific protein 65kDa (RPE65)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS